Nanoparticle and Protein Corona
暂无分享,去创建一个
Morteza Mahmoudi | L'Hocine Yahia | Nancy Tawil | Sophie Laurent | L. Yahia | M. Mahmoudi | S. Laurent | M. Rahman | N. Tawil | M. Mizanur Rahman | Masoud Rahman | Nancy Tawil
[1] P. Cullis,et al. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. , 1998, Advanced drug delivery reviews.
[2] Warren C W Chan,et al. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.
[3] Albert Duschl,et al. Time evolution of the nanoparticle protein corona. , 2010, ACS nano.
[4] Ji-Ho Park,et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. , 2009, Biomaterials.
[5] R. Müller,et al. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] Kenneth A. Dawson,et al. Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.
[7] D. Devine,et al. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. , 1998, Archives of biochemistry and biophysics.
[8] Darren J. Martin,et al. Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.
[9] I. Singh,et al. Fever and the heat shock response: distinct, partially overlapping processes , 2000, Cell stress & chaperones.
[10] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[11] Wolfgang J Parak,et al. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.
[12] R. Müller,et al. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.
[13] M. Mahmoudi,et al. Plasma concentration gradient influences the protein corona decoration on nanoparticles , 2013 .
[14] V. Rotello,et al. Biomimetic interactions of proteins with functionalized nanoparticles: a thermodynamic study. , 2007, Journal of the American Chemical Society.
[15] R. Müller,et al. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. , 2005, International journal of pharmaceutics.
[16] W. Lemm,et al. The Vroman effect , 1991 .
[17] Roberto Cingolani,et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.
[18] D. Simberg,et al. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems , 2011, Expert opinion on drug delivery.
[19] Morteza Mahmoudi,et al. Variation of protein corona composition of gold nanoparticles following plasmonic heating. , 2014, Nano letters.
[20] H. Tsukada,et al. Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. , 1996, Biochimica et biophysica acta.
[21] S. Moghimi,et al. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol‐rich liposomes , 1988, FEBS letters.
[22] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[23] K. Dawson,et al. Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. , 2007, Nano letters.
[24] R. Müller,et al. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.
[25] Iseult Lynch,et al. The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.
[26] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[27] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[28] Steven M. Slack,et al. The Vroman Effect: A Critical Review , 1995 .
[29] R. Müller,et al. Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. , 2012, International journal of pharmaceutics.
[30] Raimo Hartmann,et al. Temperature: the "ignored" factor at the NanoBio interface. , 2013, ACS nano.
[31] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[32] M. Mahmoudi,et al. Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.
[33] L. Vroman,et al. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. , 1980, Blood.